FDA Requests Recall of Zantac and All Other Ranitidine Products
On April 1, the U.S. Food and Drug Administration (FDA) announced it was asking manufacturers of all Zantac products to do a full recall because of an unsafe level of a potential cancer-causing impurity in these drugs. This includes all prescription and over-the-counter products.
This is the latest in a series of recalls related to the impurity N-Nitrosodimethylamine (NDMA), which is a probable human carcinogen, or cancer-causing substance. Now the FDA has determined the amount of this impurity increases over time when products are stored at higher than room temperature.
In summer 2019, the FDA found out about independent laboratory testing that revealed NDMA in ranitidine. While small amounts of this substance are commonly found in food and water, sustained exposure to large amounts of this substance could increase your risk of developing cancer.
This led the FDA to issue a warning to the public in September 2019 because they did not have enough evidence to determine whether it was safe to continue taking these medications. The FDA advised the public to consider alternatives to this medication.
New tests done by the FDA found NDMA levels increase in ranitidine even under normal storage conditions. Also, testing showed the older a ranitidine product is, the higher the level of NDMA it is likely to have.
The FDA sent letters to all manufacturers requesting withdrawal of these medications. The FDA advised consumers to stop taking over-the-counter ranitidine products, dispose of them properly, and not buy more. Those taking prescriptions should speak to their health care provider about alternatives before they stop taking this medication.
As we are in the midst of the COVID-19 pandemic, the FDA is telling patients and consumers not to take these medications to a drug take-back location but follow specific disposal instructions in the medication guide or package insert.
Schedule a Free Consultation if You Developed Cancer While on Zantac
TSR Injury Law offers a free consultation to those who developed bladder or stomach cancer while taking Zantac or other ranitidine medications. Research has linked these medications to a higher risk of cancer because of a harmful impurity.
Our Bloomington defective product lawyers may be able to pursue compensation for the costs of medical treatment, lost wages, pain and suffering, and other damages you may have suffered.
Our firm has recovered $300 million on behalf of our clients, and we have extensive knowledge of relevant laws and deadlines. Our goal is to obtain maximum compensation for your damages. No upfront fees for our services.
We are ready to take your call 24/7. (612) TSR-TIME